Sign in

CIK 0001730430

  • Large accelerated filer

Kiniksa Pharmaceuticals International, plc

Sign in to watch
Ticker
KNSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981795578
Phone
+1 781-431-9100
Business address
105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
Former names
Kiniksa Pharmaceuticals, Ltd.
  1. 4 Planned sale CHIEF OPERATING OFFICER sold 12,000 shares at $26.41 ($316,920)
  2. 4 Planned sale CHAIRMAN & CEO sold 2,872 shares at $27.03 ($77,630)
  3. 4 Planned sale CHAIRMAN & CEO sold 8,095 shares at an average $27.04 ($218,866)
  4. 4 Planned sale CHIEF MEDICAL OFFICER sold 200 shares at $27.00 ($5,400)
  5. 4 Planned sale CHIEF ACCOUNTING OFFICER sold 17,647 shares at $26.69 ($470,998)
  6. 4 Planned sale CHIEF COMMERCIAL OFFICER sold 10,122 shares at $28.00 ($283,416)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Planned sale CHIEF COMMERCIAL OFFICER sold 87,269 shares at an average $25.96 ($2,265,339)
  13. 4 Planned sale CHIEF FINANCIAL OFFICER sold 88,395 shares at an average $26.56 ($2,347,335)
  14. 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 479 shares (to pay taxes)
  15. 4 Planned sale CHIEF COMMERCIAL OFFICER sold 18,259 shares at $20.29 ($370,475)
  16. 4 Planned sale CHIEF OPERATING OFFICER sold 12,000 shares at an average $20.48 ($245,812)
  17. 4 Shares withheld for taxes CHIEF OPERATING OFFICER gave up 801 shares (to pay taxes)
  18. 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 1,303 shares (to pay taxes)
  19. 4 Shares withheld for taxes CHAIRMAN & CEO gave up 4,832 shares (to pay taxes)
  20. 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 734 shares (to pay taxes)

Page 6 of 20 · 386 filings